Ketamine, a powerful dissociative anesthetic with broad clinical applications, is used in various settings ranging from surgical anesthesia to treatment-resistant depression and chronic pain. Its versatility and effectiveness are closely tied to its dose, formulation, and route of administration. Understanding ketamine’s drug dose—and how that varies by condition—is essential for medical professionals and patients alike.
Ketamine (generic name: ketamine hydrochloride) is a Schedule III controlled substance approved for anesthesia but frequently used off-label for depression, anxiety, and chronic pain. It is available in multiple forms and concentrations, including 10 mg/mL, 50 mg/mL, and 100 mg/mL solutions, and under brand names like Ketalar.
The route of administration affects onset, duration, and ketamine dosage. For instance, IV ketamine induces anesthesia within seconds, while oral ketamine has a slower onset and lower bioavailability.
When used for general anesthesia, ketamine’s drug dose depends on patient weight, medical history, and route of delivery.
The ketamine IV dose is commonly used in operating rooms, while the IM ketamine dose is preferred for emergency or outpatient procedures.
Ketamine’s drug dose for sedation is lower than for full anesthesia. In procedural sedation:
These doses help achieve dissociation without full loss of consciousness, making ketamine ideal for short, non-invasive procedures. In children, precise pediatric ketamine dose calculation is critical due to potential side effects.
For chronic pain and psychiatric applications, lower doses are used over longer periods:
These sub-anesthetic doses are tailored to avoid side effects while providing neuroplastic and analgesic benefits. Protocols vary, but ketamine infusion dosing often involves repeated sessions under clinical supervision.
Ketamine infusion dose mg/kg/hr and ketamine infusion dose mcg/kg/min vary depending on patient response, age, and treatment goals.
Forms and Strengths of Ketamine: Dosage Chart by Delivery MethodKetamine is available in a variety of forms, each with specific strengths and tailored dosing requirements. This versatility allows clinicians to choose the most appropriate route based on the therapeutic goal—whether it’s general anesthesia, procedural sedation, chronic pain relief, or mental health treatment. Understanding how ketamine is administered through different delivery methods is crucial for ensuring the proper dose is given, especially since ketamine’s bioavailability and onset time can vary widely depending on the form.
Intravenous (IV) ketamine, often used in hospital and surgical settings, has nearly 100% bioavailability and provides the most immediate onset. A standard ketamine IV dose typically ranges from 1 to 4.5 mg/kg for anesthesia induction, while sedation or depression treatment often uses lower infusion rates such as 0.5 mg/kg administered over 40 minutes. IV ketamine is also commonly used in infusion therapy protocols for managing treatment-resistant depression, anxiety, or chronic pain conditions. In this setting, the ketamine infusion dose per kg is often titrated between 0.1 to 0.5 mg/kg/hr depending on the patient’s weight, metabolic response, and therapeutic goals.
Intramuscular (IM) ketamine is a popular alternative when IV access is not available. The standard IM ketamine dose for sedation in adults ranges between 4 to 13 mg/kg, offering a longer duration of effect compared to IV. This method is frequently used in emergency medicine and field anesthesia due to its ease of administration and reliable sedation profile. The IM route is also favored in pediatric cases, with dosing generally around 4 to 5 mg/kg depending on the child’s weight and procedure type.
In outpatient and at-home care settings, oral ketamine doses are becoming increasingly popular, particularly for mental health indications such as depression, PTSD, and anxiety. Oral ketamine tablets, troches, and lozenges are usually prescribed in doses ranging from 50 mg to 300 mg depending on the patient’s prior exposure and symptom severity. Due to its lower bioavailability—estimated around 20%—oral ketamine requires higher initial doses than its IV or IM counterparts to achieve a similar therapeutic response. The oral ketamine dosage for depression is often tailored over time, starting low and gradually increasing to find the optimal balance between effectiveness and tolerability.
Sublingual ketamine offers another route with improved bioavailability over oral swallowing, as it bypasses first-pass metabolism in the liver. This form, usually delivered as a lozenge or troche, dissolves under the tongue and is absorbed into the bloodstream. Common sublingual ketamine doses for depression or anxiety range from 100 mg to 300 mg per session, administered under supervision or through structured at-home protocols. Like other forms, dosing depends on individual response, body weight, and the patient’s prior ketamine exposure.
Intranasal ketamine—commonly associated with esketamine (Spravato)—is also used for rapid treatment of depression or acute mental health crises. While this formulation is generally FDA-approved under specific brand names, compounded ketamine nasal sprays are also used off-label, with doses around 28 to 56 mg per session. The intranasal route provides moderate bioavailability and a rapid onset, making it an ideal option for patients who require quick symptom relief but prefer non-invasive options.
Regardless of the form, ketamine is typically stored in vials labeled with concentrations such as 10 mg/mL, 50 mg/mL, and 100 mg/mL. These ketamine injection doses are carefully drawn and diluted based on the patient’s required dose per kilogram. Providers must consider the concentration and volume when preparing a ketamine injection, especially when using high-potency vials for IV push or infusion purposes.
Overall, each ketamine form—whether it be IV, IM, oral, sublingual, or intranasal—requires its own dosing considerations based on the patient’s needs and the condition being treated. From ketamine sedation doses in adults to ketamine infusion rates for depression, the dose per kg must be carefully calculated to avoid underdosing or excessive sedation. This underscores the importance of understanding ketamine dosage by delivery route, ensuring safe, effective, and individualized treatment.
Asana Recovery works with most PPO plans, covering up to 100%. See if your insurance can help fund your journey. Click below to get a free quote.
Before prescribing ketamine, consider these ketamine contraindications:
Ketamine is not recommended in patients under 16 unless clinically justified. Additionally, low-dose ketamine side effects should be monitored even at sub-anesthetic levels.
Common Side Effects:
IV ketamine push rate should be slow (over 60 seconds) to prevent respiratory depression or hypertensive crises.
The side effects of low-dose ketamine are usually mild but may include:
Understanding ketamine’s drug dose side effects ensures safer application across use cases. Reactions can vary depending on route of administration, patient metabolism, and interaction with other medications.
How is ketamine administered? It can be:
These options make ketamine injection uses more adaptable for individual needs. Precise administration is key to avoiding adverse effects and achieving the desired therapeutic result.
The optimal ketamine dose depends on the patient’s condition, weight, tolerance, and route of administration. Whether used for anesthesia, procedural sedation, or psychiatric therapy, understanding ketamine dose per kg is essential to ensuring effective and safe treatment.
By staying updated on current ketamine dosage charts, clinicians can provide tailored treatment protocols that minimize risks while maximizing therapeutic benefits. From ketamine injection dose in surgical settings to oral ketamine doses for depression, precision in ketamine therapy has never been more important.
In summary, understanding ketamine’s drug dose variations, contraindications, and uses allows for safer, more effective application across a range of conditions, ensuring its continued role as a powerful and flexible treatment option.
If you or a loved one is exploring ketamine therapy for depression, anxiety, or chronic pain, Asana Recovery offers compassionate, medically supervised treatment in a safe and supportive environment. Our expert team tailors each ketamine dose and administration method to your unique needs, ensuring the highest standard of care. Take the next step toward healing—contact Asana Recovery today to learn how ketamine therapy can be part of your recovery journey.
We get it. Addiction recovery is tough. That’s why our programs are founded and staffed by people in recovery – people who truly understand.
The standard ketamine dose for sedation in adults depends on the route of administration. Intravenously, ketamine is typically administered at 0.5 to 1 mg/kg for procedural sedation. For intramuscular use, the dose ranges from 4 to 5 mg/kg. These sedation doses are widely used in emergency departments and outpatient surgical settings where ketamine’s dissociative properties provide reliable sedation without the need for intubation. The dose of ketamine may be adjusted based on patient weight, medical history, and tolerance.
For general anesthesia, the ketamine induction dose is commonly calculated by weight. The IV ketamine dose per kg ranges from 1 to 4.5 mg/kg, with 2 mg/kg providing approximately 5 to 10 minutes of surgical anesthesia. The IM ketamine dose for anesthesia generally falls between 6.5 to 13 mg/kg. The precise dose varies depending on the procedure, the patient’s condition, and whether other anesthetic agents are being used in combination with ketamine.
Ketamine is often used off-label in sub-anesthetic doses for treating depression, anxiety, PTSD, and chronic pain. The typical IV ketamine infusion dose for depression is 0.5 mg/kg infused over 40 minutes, although some patients respond well to lower microdoses, such as 0.1 mg/kg/hr. Oral and sublingual ketamine doses for depression may range from 50 mg to 300 mg depending on individual factors. When administered orally, ketamine’s bioavailability is lower, which requires higher initial doses to achieve therapeutic effects.
Ketamine comes in multiple forms, including IV, IM, oral tablets or lozenges, sublingual troches, and intranasal sprays. Each route affects how much ketamine is absorbed (its bioavailability), how fast it works (onset), and how long the effects last (duration). For example, IV ketamine has near 100% bioavailability and provides immediate effect, while oral ketamine dosage must be increased due to a bioavailability of around 20%. When using ketamine tablets or troches, doses are usually higher but longer lasting.
There are several ketamine contraindications that clinicians must consider before treatment. These include a history of psychosis or schizophrenia, severe cardiovascular conditions, uncontrolled hypertension, and elevated intracranial pressure. Ketamine is also used cautiously in pediatric patients under 16, as long-term safety data is limited. Additionally, ketamine’s drug dose side effects—especially at high doses—can include hallucinations, respiratory depression, increased heart rate, and blood pressure spikes. Close monitoring during administration is essential to mitigate these risks.
Ketamine dosing is typically based on body weight (mg/kg) and adjusted according to the desired effect (anesthesia, sedation, pain relief, or antidepressant response). Providers use ketamine dosage charts or calculators to determine the appropriate ketamine dose per kg, considering factors such as administration route, the patient’s condition, and other concurrent medications. Ketamine injection doses should be carefully drawn from vials labeled with concentrations such as 10 mg/mL, 50 mg/mL, or 100 mg/mL.
There is no absolute “maximum dose” of ketamine that applies to all situations because safe dosing depends heavily on the route, clinical context, and individual patient factors. However, ketamine doses above 4.5 mg/kg IV or 13 mg/kg IM are rarely used due to increased risk of adverse effects. In mental health applications, doses are much lower and carefully titrated. For low-dose ketamine infusion therapy, clinicians generally stay below 0.5 mg/kg/hr to minimize side effects while maintaining therapeutic efficacy.
Ketalar is a common brand name for ketamine hydrochloride injection. While Ketalar and generic ketamine injections contain the same active ingredient, differences may exist in packaging, excipients, or cost. Clinicians should always verify the concentration (e.g., 50 mg/mL or 100 mg/mL) when using Ketalar or generic ketamine, especially when preparing IV infusions or IM injections.
Certain forms of ketamine, such as oral ketamine tablets, troches, or sublingual lozenges, may be prescribed for at-home use under strict clinical supervision, particularly for mental health treatment. At-home ketamine therapy requires a clear protocol, patient education, and safety monitoring. These ketamine administration routes are gaining popularity but should never be used without a healthcare provider’s guidance.
The duration of ketamine’s action depends on the dose and delivery method. IV ketamine provides effects within 30 seconds and lasts 5 to 10 minutes for anesthesia. IM ketamine lasts longer—typically 20 to 30 minutes. Oral and sublingual ketamine have a slower onset (15–30 minutes) but can last up to 90 minutes. The ketamine half-life, particularly for IV use, is around 2.5 hours, although its dissociative and therapeutic effects may wear off sooner.
Green, S. M., & Krauss, B. S. (2014). The clinical practice of procedural sedation and analgesia. Western Journal of Emergency Medicine, 15(1), 15–20. https://pmc.ncbi.nlm.nih.gov/articles/PMC4258981/
McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., et al. (2018). Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An updated review. Current Neuropharmacology, 16(5), 643–653. https://pmc.ncbi.nlm.nih.gov/articles/PMC6023582/
Drugs.com. (2023, August 16). Ketamine: Uses, dosage, side effects. https://www.drugs.com/ketamine.html
Emergency Care BC. (n.d.). Ketamine for acute and chronic pain – Clinical summary. https://emergencycarebc.ca/clinical_resource/clinical-summary/ketamine-for-acute-and-chronic-pain/
Drugs.com. (2023, August 16). Ketamine dosage guide with precautions. https://www.drugs.com/dosage/ketamine.html
Take your first step towards lasting recovery. At Asana, we offer effective, insurance-covered treatment for addiction and mental health, guided by experts who understand because they’ve been there. Start your healing today.
This book has helped so many men and women; and we want to give it you for FREE. Get signed up today and discover how to unlock the grip of addiction and get back to living your best life.
In this book, you’ll discover…
— The Most Common Misconceptions About Addiction and Rehab
— Why Rock Bottom is a Myth and What You Can Do About It
–The Steps to Healing From Trauma, Both Mentally and Emotionally
–And much more!
© Copyright 2024 Asana Recovery™ | All Rights Reserved | Privacy Policy
You could save up to 100% of your treatment using your Insurance.
By submitting this form, you agree to Asana Recovery’s Privacy Policy. You also consent to Asana Recovery contacting you by phone, text message, and email regarding your insurance benefits and treatment services. You acknowledge that text messaging may involve risks, authorize the use of your Protected Health Information (PHI) for these communications, and understand you can opt-out of text messages at any time by replying “STOP”.
Asana Recovery
We firmly believe that the internet should be available and accessible to anyone, and are committed to providing a website that is accessible to the widest possible audience, regardless of circumstance and ability.
To fulfill this, we aim to adhere as strictly as possible to the World Wide Web Consortium’s (W3C) Web Content Accessibility Guidelines 2.1 (WCAG 2.1) at the AA level. These guidelines explain how to make web content accessible to people with a wide array of disabilities. Complying with those guidelines helps us ensure that the website is accessible to all people: blind people, people with motor impairments, visual impairment, cognitive disabilities, and more.
This website utilizes various technologies that are meant to make it as accessible as possible at all times. We utilize an accessibility interface that allows persons with specific disabilities to adjust the website’s UI (user interface) and design it to their personal needs.
Additionally, the website utilizes an AI-based application that runs in the background and optimizes its accessibility level constantly. This application remediates the website’s HTML, adapts Its functionality and behavior for screen-readers used by the blind users, and for keyboard functions used by individuals with motor impairments.
If you’ve found a malfunction or have ideas for improvement, we’ll be happy to hear from you. You can reach out to the website’s operators by using the following email
Our website implements the ARIA attributes (Accessible Rich Internet Applications) technique, alongside various different behavioral changes, to ensure blind users visiting with screen-readers are able to read, comprehend, and enjoy the website’s functions. As soon as a user with a screen-reader enters your site, they immediately receive a prompt to enter the Screen-Reader Profile so they can browse and operate your site effectively. Here’s how our website covers some of the most important screen-reader requirements, alongside console screenshots of code examples:
Screen-reader optimization: we run a background process that learns the website’s components from top to bottom, to ensure ongoing compliance even when updating the website. In this process, we provide screen-readers with meaningful data using the ARIA set of attributes. For example, we provide accurate form labels; descriptions for actionable icons (social media icons, search icons, cart icons, etc.); validation guidance for form inputs; element roles such as buttons, menus, modal dialogues (popups), and others. Additionally, the background process scans all the website’s images and provides an accurate and meaningful image-object-recognition-based description as an ALT (alternate text) tag for images that are not described. It will also extract texts that are embedded within the image, using an OCR (optical character recognition) technology. To turn on screen-reader adjustments at any time, users need only to press the Alt+1 keyboard combination. Screen-reader users also get automatic announcements to turn the Screen-reader mode on as soon as they enter the website.
These adjustments are compatible with all popular screen readers, including JAWS and NVDA.
Keyboard navigation optimization: The background process also adjusts the website’s HTML, and adds various behaviors using JavaScript code to make the website operable by the keyboard. This includes the ability to navigate the website using the Tab and Shift+Tab keys, operate dropdowns with the arrow keys, close them with Esc, trigger buttons and links using the Enter key, navigate between radio and checkbox elements using the arrow keys, and fill them in with the Spacebar or Enter key.Additionally, keyboard users will find quick-navigation and content-skip menus, available at any time by clicking Alt+1, or as the first elements of the site while navigating with the keyboard. The background process also handles triggered popups by moving the keyboard focus towards them as soon as they appear, and not allow the focus drift outside it.
Users can also use shortcuts such as “M” (menus), “H” (headings), “F” (forms), “B” (buttons), and “G” (graphics) to jump to specific elements.
We aim to support the widest array of browsers and assistive technologies as possible, so our users can choose the best fitting tools for them, with as few limitations as possible. Therefore, we have worked very hard to be able to support all major systems that comprise over 95% of the user market share including Google Chrome, Mozilla Firefox, Apple Safari, Opera and Microsoft Edge, JAWS and NVDA (screen readers).
Despite our very best efforts to allow anybody to adjust the website to their needs. There may still be pages or sections that are not fully accessible, are in the process of becoming accessible, or are lacking an adequate technological solution to make them accessible. Still, we are continually improving our accessibility, adding, updating and improving its options and features, and developing and adopting new technologies. All this is meant to reach the optimal level of accessibility, following technological advancements. For any assistance, please reach out to